Does CLADRIBINE Cause Malignant neoplasm progression? 19 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 19 reports of Malignant neoplasm progression have been filed in association with CLADRIBINE (Cladribine). This represents 0.3% of all adverse event reports for CLADRIBINE.
19
Reports of Malignant neoplasm progression with CLADRIBINE
0.3%
of all CLADRIBINE reports
13
Deaths
0
Hospitalizations
How Dangerous Is Malignant neoplasm progression From CLADRIBINE?
Of the 19 reports, 13 (68.4%) resulted in death, and 2 (10.5%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CLADRIBINE. However, 19 reports have been filed with the FAERS database.
What Other Side Effects Does CLADRIBINE Cause?
Fatigue (696)
Headache (579)
Lymphocyte count decreased (448)
Multiple sclerosis relapse (404)
Nausea (354)
Pneumonia (318)
White blood cell count decreased (311)
Urinary tract infection (242)
Pyrexia (207)
Multiple sclerosis (206)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which CLADRIBINE Alternatives Have Lower Malignant neoplasm progression Risk?
CLADRIBINE vs CLARAVIS
CLADRIBINE vs CLARITHROMYCIN
CLADRIBINE vs CLARITIN
CLADRIBINE vs CLARITIN CHEWABLE
CLADRIBINE vs CLARITIN-D-12